Reverse transcriptase inhibitors in HIV/AIDS therapy

Author(s)

• Skowron, Gail
• Ogden, Richard C.

Bibliographic Information

Reverse transcriptase inhibitors in HIV/AIDS therapy

edited by Gail Skowron, Richard Ogden

（Infectious disease）

Humana Press, c2006

Note

foreword by Joep M.A. Lange

Includes bibliographical references and index

Contents of Works

• Structural studies on HIV reverse transcriptase related to drug discovery / David K. Stammers and Jingshan Ren
• Zidovudine, lamivudine, and abacavir / Monica Carten and Harold Kessler
• Stavudine, didanosine, and zalcitabine / Gail Skowron, Sapna Chowdhry and Michael R. Stevens
• Emtricitabine / Gail Skowron, Jeffrey Bratberg and Rudi Pauwels
• Nucleotide analogs / Craig J. Hoesley
• Resistance to nucleoside and nucleotide reverse transcriptase inhibitors / Nancy Shulman and Mark Winters
• Pharmacokinetics of reverse transcriptase inhibitors / Patrick Hoggard ... [et al.]
• Peripheral neuropathy associated with nucleoside reverse transcriptase inhibitor therapy / Bruce A. Cohen and Russell Bartt
• Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: a pathophysiological perspective / William Lewis
• Mitochondrial toxicity and lipodystrophy / Grace McComsey
• Nevirapine / David Asmuth and Richard Pollard
• Efavirenz / Graeme J. Moyle and Brian Conway
• Delavirdine / Brian Conway
• Resistance to non-nucleoside reverse transcriptase inhibitors / F. Ramzi Asfour and Richard Haubrich
• Vertical transmission of HIV and therapeutic interventions / Susan Cu-Uvin, Arlene Bardeguez and Carla Chibwesha
• New reverse transcriptase inhibitors in development / Rudi Pauwels
• Antiretroviral drugs for millions / Allan Ronald, Ellie Katabira and Merle Sande

Description and Table of Contents

Description

A magisterial survey of all aspects of the reverse transcriptase inhibitors (RTIs) used to treat HIV/AIDS, including drug discovery, pharmacology, development of drug resistance, toxicity, and prevention of mother-to-child transmission of HIV/AIDS. The authors synthesize our current understanding of the role of reverse transcriptase in the viral life cycle, describe the discovery and development of eight nucleoside and nucleotide analogs that represent milestones in treatment history, and thoroughly discuss the question of toxicity and resistance to this class of drugs. They also address three non-nucleoside RTIs and their pharmacokinetics and comparative clinical efficacy, new RTIs currently under development, and the impact of approved agents on treatment, in general, and on vertical transmission in the developing world.

Table of Contents

Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery David K. Stammers and Jingshan Ren Zidovudine, Lamivudine, and Abacavir Monica Carten and Harold Kessler Stavudine, Didanosine, and Zalcitabine Gail Skowron, Sapna Chowdhry, and Michael R. Stevens Emtricitabine Gail Skowron, Jeffrey Bratberg, and Rudi Pauwels Nucleotide Analogs Craig J. Hoesley Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Nancy Shulman and Mark Winters Pharmacokinetics of Reverse Transcriptase Inhibitors Patrick Hoggard, Stephen Kewn, Saye Khoo and David Back Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy Bruce A. Cohen and Russell Bartt Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy: A Pathophysiological Perspective William Lewis Mitochondrial Toxicity and Lipodystrophy Grace McComsey Nevirapine David Asmuth and Richard Pollard Efavirenz Graeme J. Moyle and Brian Conway Delavirdine Brian Conway Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors F. Ramzi Asfour and Richard Haubrich Vertical Transmission of HIV and Therapeutic Interventions Susan Cu-Uvin, Arlene Bardeguez, and Carla Chibwesha New Reverse Transcriptase Inhibitors in Development Rudi Pauwels Antiretroviral Drugs for Millions Allan Ronald, Elly Katabira, and Merle Sande Postscript Richard Ogden and Gail Skowron Index

by "Nielsen BookData"

Details

• NCID: BB18169239
• ISBN:
  • 1588296490
• LCCN: 2005033190
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Totowa, N.J.
• Pages/Volumes: xiii, 527 p.
• Size: 24 cm
• Classification:
  • LCC : RC606.7
  • NLM : 2006 G-977
  • NLM : WC 503.2
  • DC22 : 616.97/92061
• Subject Headings:
  • LCSH : AIDS (Disease) -- Chemotherapy
  • LCSH : HIV infections -- Chemotherapy
  • LCSH : Reverse transcriptase -- Inhibitors -- Therapeutic use
  • LCSH : Antiretroviral agents
  • MESH : Acquired Immunodeficiency Syndrome -- drug therapy
  • MESH : HIV Infections -- drug therapy
  • MESH : Reverse Transcriptase Inhibitors -- therapeutic use
• Parent Bibliography ID:
  • BA52030620